Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Recurrence within 6 months of platinum therapy": an adequate definition of "platinum-refractory" ovarian cancer?

× No keyword cloud information.

5 in total

Review 1. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.

Authors: Daniela Luvero; Andrea Milani; Jonathan A Ledermann
Journal: Ther Adv Med Oncol Date: 2014-09 Impact factor: 8.168

2. Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

Authors: Shin Nishio; Noriyuki Katsumata; Koji Matsumoto; Hiroshi Tanabe; Kan Yonemori; Tsutomu Kouno; Chikako Shimizu; Masashi Ando; Toshiharu Kamura; Takahiro Kasamatsu; Yasuhiro Fujiwara
Journal: J Cancer Res Clin Oncol Date: 2008-10-01 Impact factor: 4.553

3. Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study.

Authors: Antonio Macrì; Fabio Accarpio; Vincenzo Arcoraci; Francesco Casella; Franco De Cian; Pierandrea De Iaco; Elena Orsenigo; Franco Roviello; Giovanni Scambia; Edoardo Saladino; Marica Galati
Journal: Pleura Peritoneum Date: 2020-12-04

4. Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.

Authors: Francesco Legge; Marco Petrillo; Vincenzo Adamo; Salvatore Pisconti; Giovanni Scambia; Gabriella Ferrandina
Journal: BMC Cancer Date: 2008-12-12 Impact factor: 4.430

5. Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma.

Authors: Sanjay Sharma; Michael H Neale; Federica Di Nicolantonio; Louise A Knight; Pauline A Whitehouse; Stuart J Mercer; Bernard R Higgins; Alan Lamont; Richard Osborne; Andrew C Hindley; Christian M Kurbacher; Ian A Cree
Journal: BMC Cancer Date: 2003-07-03 Impact factor: 4.430

5 in total